Project Grant R01NS133338
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$669K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This federal Project Grant award of $173,140 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the role of neural activity in the degeneration of midbrain dopamine neurons, which is a key feature of Parkinson's disease. The research project, which runs from September 30, 2024 to June 30, 2027, will utilize novel mouse models to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to determine changes in synaptic vesicle-binding of alpha-synuclein as an early biomarker for Parkinson's disease and Alzheimer's disease related dementias. The $793,535 award to Weill Medical College of Cornell University aims to: 1) identify the gastrointestinal area...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $2,208,982.00 to the San Diego Biomedical Research Institute to conduct research on the role of the interleukin-13 receptor (IL-13RA1) in regulating the viability of dopaminergic neurons and its potential contribution to Parkinson's disease pathogenesis. The key objectives are to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is providing $647,116 to the Regents of the University of Michigan to characterize and target a novel pathway promoting Parkinson's disease (PD) and Parkinson's disease dementia (PDD). The funded research aims to investigate how the interaction between the protease tissue...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to establish the role of alpha-synuclein-mediated membrane permeabilization in the spread of alpha-synuclein aggregates related to Parkinson's disease and related dementias. The $406,260 award to Purdue University will leverage fluorescence lifetime imaging microscopy...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders" supports research focused on developing a nano scavenger-based diagnostic and therapeutic strategy for Parkinson's disease. The $799,127 award to Baylor College of Medicine aims to establish the preclinical potential of a nano scavenger agent that can bind to and facilitate clearance of...
This $475,475 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The goal of the award is to evaluate a small molecule inhibitor of the USP30 enzyme as a potential neuroprotective therapy for Parkinson's disease. The research will assess...
This Project Grant award of $616,200.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The objective is to study the influence of neuromelanin, a dark pigment found in dopamine neurons, on the degeneration of these neurons in Parkinson's disease. The research will leverage a novel mouse model developed by a sub-awardee, Emory University,...
This federal Project Grant award of $684,451 was provided by the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, to Weill Medical College of Cornell University. The award supports a 5-year research project aimed at: 1) identifying progression subtypes of Parkinson's disease (PD) through integrative modeling of longitudinal clinical, transcriptomic, and neuroimaging data;...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $682,493 to the Albert Einstein College of Medicine to elucidate the role of aberrant histone acetylation in the pathogenesis of Parkinson's disease and related synucleinopathies. The research involves utilizing a human pluripotent stem cell-based discovery platform...